Hepatology International

The saga of entecavir
pp. 421-424(4)
Authors: Lai, Ching-Lung; Yuen, Man-Fung

HBeAg seroconversion as an important end point in the treatment of chronic hepatitis B
pp. 425-433(9)
Author: Liaw, Yun-Fan

The global burden of iron overload
pp. 434-444(11)
Authors: Wood, Marnie; Skoien, Richard; Powell, Lawrie

Antiviral activity, dose-response relationship, and safety of entecavir following 24-week oral dosing in nucleoside-naive Japanese adult patients with chronic hepatitis B: a randomized, double-blind, phase II clinical trial
pp. 445-452(8)
Authors: Shindo, Michiko; Chayama, Kazuaki; Mochida, Satoshi; Toyota, Joji; Tomita, Eiichi; Kumada, Hiromitsu; Yokosuka, Osamu; Sata, Michio; Hayashi, Norio; Suzuki, Kazuyuki; Okanoue, Takeshi; Tsubouchi, Hirohito; Ishikawa, Hiroki; Seriu, Taku; Omata, Masao

Patterns of managing chronic hepatitis B treatment-related drug resistance: a survey of physicians in Mainland China, South Korea, Taiwan, and Thailand
pp. 453-460(8)
Authors: Chainuvati, Siwaporn; Cheng, Jun; Hou, Jin; Hsu, Chao; Jia, Ji; Komolmit, Piyawat; Kwon, So; Lee, Chang; Li, Hong; Li, Ying; Liu, Chun; Neo, Boon; Peng, Cheng; Tanwandee, Tawesak; Wongcharatrawee, Suchat; Wu, Jaw; Yu, Ming; Zhang, Xin

Prevalence of hepatitis B virus genotype B in Vietnamese patients with chronic hepatitis B
pp. 461-467(7)
Authors: Nguyen, Long; Ha, Nghiem; Vutien, Philip; Ha, Nghi; Garcia, Ruel; Trinh, Huy; Levitt, Brian; Nguyen, Huy; Nguyen, Khanh; Keeffe, Emmet; Nguyen, Mindie

A randomized trial of 24 versus 48 weeks of peginterferon α-2a in patients infected with chronic hepatitis C virus genotype 2 or low viral load genotype 1: a multicenter national study in Japan
pp. 468-479(12)
Authors: Iwasaki, Yoshiaki; Shiratori, Yasushi; Hige, Shuhei; Nishiguchi, Shuhei; Takagi, Hitoshi; Onji, Morikazu; Yoshida, Haruhiko; Izumi, Namiki; Kohgo, Yutaka; Yamamoto, Kyosuke; Sato, Nobuhiro; Shibuya, Akitaka; Saito, Hidetsugu; Sata, Michio; Suzuki, Kazuyuki; Kaneko, Shuichi; Moriyama, Mitsuhiko; Omata, Masao

A randomized controlled trial of thymalfasin plus transarterial chemoembolization for unresectable hepatocellular carcinoma
pp. 480-489(10)
Authors: Gish, Robert; Gordon, Stuart; Nelson, David; Rustgi, Vinod; Rios, Israel

The state of cholesterol metabolism in the liver of patients with primary biliary cirrhosis: the role of MDR3 expression
pp. 490-496(7)
Authors: Enjoji, Munechika; Yada, Ryoko; Fujino, Tatsuya; Yoshimoto, Tsuyoshi; Yada, Masayoshi; Harada, Naohiko; Higuchi, Nobito; Kato, Masaki; Kohjima, Motoyuki; Taketomi, Akinobu; Maehara, Yoshihiko; Nakashima, Manabu; Kotoh, Kazuhiro; Nakamuta, Makoto

Effect of natural interferon α on proliferation and apoptosis of hepatic stellate cells
pp. 497-503(7)
Authors: Ogawa, Tomohiro; Kawada, Norifumi; Ikeda, Kazuo

Cerebral embolism following N-butyl-2-cyanoacrylate injection for esophageal postbanding ulcer bleed: a case report
pp. 504-508(5)
Authors: Abdullah, Asmarani; Sachithanandan, Sharmila; Tan, Ooi; Chan, Yee; Khoo, Dennise; Mohamed Zawawi, Faizal; Omar, Haniza; Tan, Soek; Oemar, Hamed

Diffuse intrahepatic recurrence after percutaneous radiofrequency ablation for solitary and small hepatocellular carcinoma
pp. 509-515(7)
Authors: Mori, Yoshiyuki; Tamai, Hideyuki; Shingaki, Naoki; Moribata, Kosaku; Shiraki, Tatsuya; Deguchi, Hisanobu; Ueda, Kazuki; Enomoto, Shotaro; Magari, Hiroto; Inoue, Izumi; Maekita, Takao; Iguchi, Mikitaka; Yanaoka, Kimihiko; Oka, Masashi; Ichinose, Masao